Page last updated: 2024-10-28

hydrochlorothiazide and Polycystic Kidney, Autosomal Dominant

hydrochlorothiazide has been researched along with Polycystic Kidney, Autosomal Dominant in 1 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Polycystic Kidney, Autosomal Dominant: Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.

Research Excerpts

ExcerptRelevanceReference
"In 562 patients with ADPKD (61% female, eGFR 63±28 ml/min per 1."1.91Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease. ( Fenton, RA; Gansevoort, RT; Geurts, F; Hoorn, EJ; Kramers, BJ; Meijer, E; Salih, M; Xue, L; Zietse, R, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Geurts, F1
Xue, L1
Kramers, BJ1
Zietse, R1
Gansevoort, RT1
Fenton, RA1
Meijer, E1
Salih, M1
Hoorn, EJ1

Other Studies

1 other study available for hydrochlorothiazide and Polycystic Kidney, Autosomal Dominant

ArticleYear
Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
    Clinical journal of the American Society of Nephrology : CJASN, 2023, 11-01, Volume: 18, Issue:11

    Topics: Antidiuretic Hormone Receptor Antagonists; Dinoprostone; Disease Progression; Female; Glomerular Fil

2023